New Hampshire HB 172: relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

Status: Inexpedient to Legislate: MA VV 01/03/2024 HJ 1 P. 34 (as of 2024-01-03)

State: New Hampshire · Session: 2024 · Bill: HB 172

Sponsors: Jess Edwards, Peter R. Leishman

View New Hampshire HB 172 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.